SomaLogic Board Reiterates Value-Maximizing Transaction with Standard BioTools is in Best Interests of All Stockholders

/PRNewswire/ -- SomaLogic, Inc. (Nasdaq: SLGC) ("the Company"), a leader in proteomics technology, today sent the following open letter to stockholders...

Related Keywords

Joele Frank ,Robert Barchi ,Carly King ,Thomas Carey ,Lyle Weston ,Anne Margulies ,Troy Cox ,Kathy Hibbs ,Wilkinson Brimmer Katcher ,Marissa Bych ,Jason Ryan ,Eli Casdin ,Exchange Commission ,Standard Biotool Investor Relations Department ,Somalogic Inc ,Nasdaq ,Gilmartin Group ,Morrow Sodali ,Linkedin ,Advisory Firm Institutional Shareholder Services ,Recommend Stockholders Vote ,Dismissed Madryn ,Misleading Claims ,Stockholders Vote ,Standard Biotools ,Fellow Stockholders ,Standard Biotools Merger ,Best Path Forward ,Follows Exhaustive ,Independent Strategic Review ,Outside Legal ,Somalogic Board ,Somalogic Board Is Independent ,Best Interests ,Logic Stockholders ,Seriesb Preferred ,Stockholders Should Vote ,Compelling Benefits ,Proposed Merger Between Somalogic ,Standard Biotools While Protecting ,Madryn Asset Management ,Special Meeting ,Standard Biotool ,Standard Biotool Investor Relations ,Somalogic Investor Relations ,Current Reports ,Securities Act ,Private Securities Litigation Reform Act ,Wilkinson Brimmer ,Somalogic ,